Andreasen N, Gottfries J, Vanmechelen E, Vanderstichele H, Davidson P, Blennow K, Rosengren L, Blennow K. Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):557-8. PubMed.
AlzBiomarker Database
Meta-Analysis
- AD vs CTRL : Aβ42 (CSF)
- CTRL vs AD : Aβ42 (CSF)
- AD vs CTRL : GFAP (CSF)
- CTRL vs AD : GFAP (CSF)
- AD vs CTRL : NFL (CSF)
- CTRL vs AD : NFL (CSF)
- AD vs CTRL : NSE (CSF)
- CTRL vs AD : NSE (CSF)
- AD vs CTRL : tau-total (CSF)
- CTRL vs AD : tau-total (CSF)
Curated Study Data
Biomarker (Source) |
Cohort (N) |
Measurement Mean ± SD |
Method; Assay Name; Manufacturer |
Diagnostic Criteria |
---|---|---|---|---|
Aβ42 (CSF) |
AD (35) |
748 ± 297 pg/mL |
ELISA; Innotest; Innogenetics |
McKhann et al., 1984 |
Aβ42 (CSF) |
CTRL- CNC (19) |
1623 ± 429 pg/mL |
ELISA; Innotest; Innogenetics |
|
GFAP (CSF) |
AD (35) |
717 ± 250 pg/mL |
ELISA; Other/Not Specified; In-house |
McKhann et al., 1984 |
GFAP (CSF) |
CTRL- CNC (19) |
860 ± 297 pg/mL |
ELISA; Other/Not Specified; In-house |
|
NFL (CSF) |
AD (35) |
615 ± 456 pg/mL |
ELISA; Other/Not Specified; In-house |
McKhann et al., 1984 |
NFL (CSF) |
CTRL- CNC (19) |
295 ± 194 pg/mL |
ELISA; Other/Not Specified; In-house |
|
NSE (CSF) |
AD (35) |
7.4 ± 2.7 ng/mL |
ELISA; Other/Not Specified; Sangtec Medical |
McKhann et al., 1984 |
NSE (CSF) |
CTRL- CNC (19) |
6.9 ± 2.1 ng/mL |
ELISA; Other/Not Specified; Sangtec Medical |
|
tau-total (CSF) |
AD (35) |
634 ± 288 pg/mL |
ELISA; Innotest; Innogenetics |
McKhann et al., 1984 |
tau-total (CSF) |
CTRL- CNC (19) |
375 ± 171 pg/mL |
ELISA; Innotest; Innogenetics |
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.